Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tanner

Showing results (841-850 of 855) with videos related to

Pageof 86
Sort By:
Scientific Data|November 28, 2025
Sentinel-2 based estimates of rangeland fractional cover and canopy gap class for the western United StatesBrady W Allred, Sarah E McCord, Timothy J Assal, et al.
JAMA Neurology|November 6, 2013
Cognitive and motor function in long-duration PARKIN-associated Parkinson diseaseRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.
Trials|October 6, 2022
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trialCharity G Patterson, Elizabeth Joslin, Alexandra B Gil, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 10, 2017
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking PalsyJ A Obeso, M Stamelou, C G Goetz, et al.
Annals of Neurology|May 11, 2026
Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMICaroline M Tanner, Craig E Stanley, Ethan G Brown, et al.
JAMA|February 11, 2015
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial, Karl Kieburtz, Barbara C Tilley, et al.
American Journal of Hypertension|September 24, 2019
Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working GroupMarguerite R Irvin, Colleen M Sitlani, James S Floyd, et al.
Neurology|August 18, 2017
National randomized controlled trial of virtual house calls for Parkinson diseaseChristopher A Beck, Denise B Beran, Kevin M Biglan, et al.
Frontiers in Genetics|January 1, 2024
Whole genome sequence analysis of apparent treatment resistant hypertension status in participants from the Trans-Omics for Precision Medicine programNicole D Armstrong, Vinodh Srinivasasainagendra, Farah Ammous, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 18, 2016
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and BarriersE Ray Dorsey, Meredith A Achey, Christopher A Beck, et al.
Pageof 86

Showing results (841-850 of 855) with videos related to

Sort By:
Pageof 86
Scientific Data|November 28, 2025
Sentinel-2 based estimates of rangeland fractional cover and canopy gap class for the western United StatesBrady W Allred, Sarah E McCord, Timothy J Assal, et al.
JAMA Neurology|November 6, 2013
Cognitive and motor function in long-duration PARKIN-associated Parkinson diseaseRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.
Trials|October 6, 2022
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trialCharity G Patterson, Elizabeth Joslin, Alexandra B Gil, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 10, 2017
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking PalsyJ A Obeso, M Stamelou, C G Goetz, et al.
Annals of Neurology|May 11, 2026
Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMICaroline M Tanner, Craig E Stanley, Ethan G Brown, et al.
JAMA|February 11, 2015
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial, Karl Kieburtz, Barbara C Tilley, et al.
American Journal of Hypertension|September 24, 2019
Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working GroupMarguerite R Irvin, Colleen M Sitlani, James S Floyd, et al.
Neurology|August 18, 2017
National randomized controlled trial of virtual house calls for Parkinson diseaseChristopher A Beck, Denise B Beran, Kevin M Biglan, et al.
Frontiers in Genetics|January 1, 2024
Whole genome sequence analysis of apparent treatment resistant hypertension status in participants from the Trans-Omics for Precision Medicine programNicole D Armstrong, Vinodh Srinivasasainagendra, Farah Ammous, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 18, 2016
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and BarriersE Ray Dorsey, Meredith A Achey, Christopher A Beck, et al.
Pageof 86